Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Paolini John F. sold 58,424 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Paolini John F. (CHIEF MEDICAL OFFICER) sold 58,424 Kiniksa Pharmaceuticals International, Plc shares at an average US$53.71 for US$3.14M under a trading plan, leaving 65,623 shares. Filed May 5, 2026 (Form 4).
- Sold
- 58,424 shares
- Price
- US$53.71 average (US$53.52 to US$54.04)
- Value
- US$3.14M
- Holding after
- 65,623 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Class A Ordinary Share | Option exercise | 58,424 | US$10.36 | 124,047 | Direct |
| May 1, 2026 | Class A Ordinary Share | Sale | 37,327 | US$53.52 | 86,720 | Direct |
| May 1, 2026 | Class A Ordinary Share | Sale | 21,097 | US$54.04 | 65,623 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Paolini John F.
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Paolini John F. · Apr 8, 2026
- Form 4 · Paolini John F. · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026